Point-of-Care Testing in Wound Care: Essential Guide

Point-of-Care Testing in Wound Care: When and What to Test

Point-of-care testing in wound care eliminates the delay between clinical suspicion and actionable data. When a wound is not healing, the underlying cause is often metabolic, vascular, or infectious, and waiting three to five days for lab results from an external reference laboratory means three to five days of suboptimal treatment. POCT brings the answer into the exam room.

The decision framework is straightforward: test when the result will change what you do today. A fasting glucose on a diabetic patient whose A1c you already know is 11.2% adds no clinical value. An ABI on a patient with absent pedal pulses and a non-healing heel ulcer changes the entire treatment plan in the same visit. Every test should have a defined clinical trigger and a documented rationale.

For comprehensive diabetic foot evaluation that incorporates these tests, see our Diabetic Foot Exam Protocol.

Glucose and Hemoglobin A1c

Point-of-Care Glucose

Capillary blood glucose testing is the most frequently performed POCT in wound care settings. The primary clinical application is identifying hyperglycemia that is actively impairing wound healing. Blood glucose levels consistently above 200 mg/dL impair neutrophil function, reduce collagen synthesis, and promote bacterial growth in wound tissue.

Test glucose at the initial wound evaluation for all diabetic patients and for any patient with a non-healing wound of unknown etiology. Repeat testing is indicated when a wound shows signs of healing arrest or deterioration in a known diabetic patient. Document the result, the time relative to last meal (fasting vs random), and the clinical action taken based on the result.

Hemoglobin A1c

Point-of-care A1c analyzers provide results in five to eight minutes using a fingerstick sample. The A1c reflects average glycemic control over the preceding 8-12 weeks and is a stronger predictor of wound healing trajectory than any single glucose reading.

An A1c above 8% in a patient with a diabetic foot ulcer correlates with significantly prolonged healing times. An A1c above 10% in a patient being considered for skin substitute application or surgical intervention should prompt glycemic optimization before proceeding, because the graft or flap failure rate rises substantially in poorly controlled diabetes.

Test A1c at initial wound evaluation for all diabetic patients and for patients with random glucose above 200 mg/dL who have no prior diabetes diagnosis. Retest every 90 days for patients whose initial A1c was above target and whose treatment plan includes glycemic optimization as a wound healing strategy.

Nutritional Markers: Albumin and Prealbumin

Serum Albumin

Albumin below 3.5 g/dL indicates protein malnutrition that impairs wound healing through reduced collagen synthesis, impaired immune function, and decreased oncotic pressure leading to tissue edema. However, albumin has a half-life of approximately 20 days, making it a poor marker of acute nutritional changes. It is also a negative acute-phase reactant, meaning it drops during infection and inflammation regardless of nutritional status.

Use albumin as a baseline nutritional screen at initial wound evaluation. Do not rely on serial albumin measurements to track the effectiveness of nutritional interventions because changes in albumin lag weeks behind actual nutritional improvement.

Prealbumin (Transthyretin)

Prealbumin has a half-life of two to three days, making it a far more responsive marker of nutritional status changes. A prealbumin below 15 mg/dL indicates significant protein malnutrition. Values between 15 and 18 mg/dL suggest mild to moderate depletion.

For patients with documented malnutrition or those receiving nutritional supplementation as part of the wound healing plan, prealbumin provides meaningful short-term tracking. Test every 7-14 days to monitor response to nutritional intervention. A rising prealbumin trend confirms that the nutritional strategy is effective, even before wound healing visibly improves.

Like albumin, prealbumin drops as an acute-phase reactant during infection and inflammation. Interpret low values cautiously in patients with active wound infection.

Wound Cultures: Technique Matters More Than Technology

When to Culture

Culture wounds when clinical signs of infection are present: increasing pain, expanding erythema, purulent drainage, wound deterioration, systemic signs (fever, elevated WBC), or non-healing despite appropriate wound care. Do not culture wounds routinely or culture wounds that show no clinical signs of infection. All chronic wounds are colonized. Culturing colonization generates results that tempt clinicians into prescribing unnecessary antibiotics.

Proper Technique for Accurate Results

Surface swab cultures of chronic wounds predominantly capture colonizing organisms rather than the pathogens driving infection. When swab culture is the available method, the Levine technique provides the most clinically relevant results.

Clean the wound with sterile saline and debride surface debris before culturing. Rotate a sterile swab over a 1 cm squared area of clean wound bed tissue with enough pressure to express fluid from the wound. Avoid culturing necrotic tissue, eschar, or surface exudate. For deep infections, tissue biopsy or needle aspiration provides superior pathogen identification.

Documentation for POCT Cultures

Document the indication for culture (specific clinical signs observed), the technique used, the anatomic location sampled, and whether the wound was cleansed and debrided before culture collection. When results return, document the organism(s) identified, susceptibility patterns, and the specific antibiotic decision made based on the results.

ABI Measurement at Point of Care

Technique and Interpretation

The ankle-brachial index is measured using a handheld continuous-wave Doppler and a blood pressure cuff. Measure systolic blood pressure in both brachial arteries and in the dorsalis pedis and posterior tibial arteries bilaterally. The ABI for each leg is the higher ankle pressure divided by the higher brachial pressure.

Normal ABI: 0.91-1.30. Mild PAD: 0.70-0.90. Moderate PAD: 0.40-0.69. Severe PAD: <0.40 (critical limb ischemia). Non-compressible arteries: >1.30 (common in diabetic and renal patients due to medial arterial calcification).

Clinical Decision Points

An ABI below 0.5 in a patient with a lower extremity wound indicates that arterial perfusion is likely inadequate for wound healing. Vascular surgery referral should precede any advanced wound therapy (skin substitutes, growth factors, NPWT). Applying a $127.14/sq cm skin substitute to an ischemic wound bed is not only clinically inappropriate but constitutes waste that payers will identify and deny on audit.

An ABI above 1.3 does not mean "excellent perfusion." It means the arteries are calcified and non-compressible, which is common in diabetes and chronic kidney disease. These patients require toe pressures (normal >30 mmHg) or transcutaneous oxygen measurements (TcPO2 >30 mmHg) for accurate perfusion assessment.

Documentation Requirements for POCT

Point-of-care test results require the same documentation rigor as reference laboratory results. Every POCT result in the medical record must include the test performed, the date and time, the result value with units, the reference range, the clinical indication for testing, and the clinical action taken based on the result.

CLIA-waived POCT devices used in wound care settings (glucometers, A1c analyzers, handheld Doppler for ABI) require a CLIA Certificate of Waiver. Maintain quality control logs per manufacturer specifications. These are not optional regulatory niceties -- they are audit targets and the absence of QC documentation can result in loss of CLIA waiver and the ability to perform any POCT.

For comprehensive documentation approaches, see our Wound Care Documentation Templates.

Key Takeaways

Test when the result will change same-day clinical decisions -- routine screening of asymptomatic parameters adds cost without improving outcomes.
A1c above 8% predicts prolonged wound healing; above 10% should trigger glycemic optimization before advanced therapies like skin substitutes.
Prealbumin (2-3 day half-life) tracks nutritional response far more effectively than albumin (20-day half-life) for short-term monitoring of nutritional interventions.
ABI above 1.3 indicates calcified arteries, not adequate perfusion -- order toe pressures or TcPO2 for accurate vascular assessment in diabetic and renal patients.
All POCT results require documentation of indication, result, reference range, and clinical action taken, plus CLIA-waived quality control logs for every device.